Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05850533 · ClinicalTrials.gov registry record · NA
Tai Chi Easy for Opioid Use Disorder, Anxiety, and Chronic Pain
A NA study of Anxiety and Chronic Pain, sponsored by Asana Recovery.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT05850533: Completed NA study of Anxiety and Chronic Pain, sponsored by Asana Recovery.
NCT05850533 is a NA study of Anxiety and Chronic Pain that has completed, run by Asana Recovery. The registered enrollment target is 19 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05850533, a NA study of Anxiety and Chronic Pain, has completed, sponsored by Asana Recovery.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
A pre-post, single-group, quasi-experimental design will be used to determine the acceptability, feasibility, and appropriateness of a theory-based, 8-week/16-session virtual Tai Chi Easy (vTCE) intervention for adults with OUD, anxiety, and chronic pain. This dissertation has three Aims: 1) Determine the feasibility of an 8-week/16-session, vTCE intervention for adults with OUD, CP, and anxiety; 2) Determine the perceptions of the vTCE intervention participants by conducting a focus group interview post-vTCE; 3) Explore within-subject changes in generalized anxiety, chronic pain intensity, opioid use, opioid cravings, and basic psychological needs post-vTCE.
Primary Outcome
recruit 20 adults within 2 months
Conditions Studied
Interventions
- BEHAVIORAL Virtual Tai Chi Easy
Study Locations (1)
California
- Asana Recovery - Costa Mesa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2023-05-22 |
| Est. Completion | 2023-10-11 |
| Phase | NA |
What the finished NCT05850533 record still lists
NCT05850533 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Virtual Tai Chi Easy is the first listed.
NCT05850533 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05850533 about?
NCT05850533 is a clinical study titled "Tai Chi Easy for Opioid Use Disorder, Anxiety, and Chronic Pain". A pre-post, single-group, quasi-experimental design will be used to determine the acceptability, feasibility, and appropriateness of a theory-based, 8-week/16-session virtual Tai Chi Easy (vTCE) intervention for adults with OUD, anxiety, and chronic pain. This dissertation has three Aims: 1) Determi...
What is the current status of trial NCT05850533?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2023-05-22. Estimated completion is 2023-10-11.
What conditions does trial NCT05850533 study?
This clinical trial studies the following conditions: Anxiety, Chronic Pain, Opioid Use Disorder.
What interventions are being tested in trial NCT05850533?
The interventions under investigation include: Virtual Tai Chi Easy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05850533?
This trial is sponsored by Asana Recovery, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05850533 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05850533's enrollment target sits among peer trials
19 332nd of 364 higher than 32 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI